Related Experiment Videos
Quinine plus clindamycin improves chemotherapy of severe malaria in children
P G Kremsner1, P Radloff, W Metzger
1International Research Laboratory, Albert-Schweitzer-Hospital, Lambaréné, Gabon.
Insights
A 4-day quinine-clindamycin regimen significantly shortened fever and parasite clearance times in children with severe malaria compared to standard 7-day quinine treatment. This new regimen reduced recurring fever episodes, offering a more effective malaria treatment option.
Area of Science:
- Tropical Medicine
- Infectious Diseases
- Clinical Pharmacology
Background:
- Severe Plasmodium falciparum malaria remains a significant threat, particularly in children.
- Standard treatment regimens require evaluation for improved efficacy and reduced side effects.
Purpose of the Study:
- To compare the efficacy of a 4-day quinine-clindamycin regimen against the standard 7-day quinine regimen in treating severe childhood malaria.
- To assess parasite clearance time, fever clearance time, and recurrence of fever.
Main Methods:
- A randomized trial involving 100 Gabonese children with severe Plasmodium falciparum malaria.
- Participants were randomized into two groups: one receiving a 4-day quinine-clindamycin regimen and the other a 7-day quinine regimen.
- Clinical outcomes including mortality, parasite clearance, fever clearance, and fever recurrence were monitored.
Main Results:
- Both regimens had similar mortality rates (1 death per group).
- The quinine-clindamycin group demonstrated significantly shorter parasite clearance times (P = 0.03) and fever clearance times (P = 0.01).
- Fewer episodes of recurring fever were observed in the quinine-clindamycin group post-treatment (P < 0.001).
Conclusions:
- A 4-day quinine-clindamycin regimen is a more effective treatment for severe Plasmodium falciparum malaria in children than the standard 7-day quinine regimen.
- This shorter regimen leads to faster parasite and fever resolution and reduces fever recurrence.
- The findings support the potential use of combined quinine-clindamycin therapy for improved pediatric malaria management.
Abstract:
In a randomized trial, a 4-day quinine-clindamycin regimen was compared with the standard 7-day quinine regimen for 100 Gabonese children (50 children in each group) with severe Plasmodium falciparum malaria. In each group, only one patient died. Parasite clearance and fever clearance times were significantly shorter in the quinine-clindamycin group (P = 0.03 and P = 0.01, respectively) than in the quinine group, and significantly more recurring fever episodes occurred in the quinine group than in the quinine-clindamycin group shortly after initial fever clearance and parasite clearance (P < 0.001).